CHINESE NPMA ANNOUNCEMENT ON IMPLEMENTING THE APPLICATION WITH ELECTRONIC COMMON TECHNICAL DOCUMENTS

As of 29 December 2021, the marketing authorization of chemicals with Registration Categories 1 and 5.1, therapeutic biological products with…

READ

MINISTERIAL DECREE OF NOVEMBER 30TH, 2021 CONCERNING NO-PROFIT CLINICAL TRIALS OF MEDICINES AND OBSERVATIONAL STUDIES

As of March 6th, 2022, with the entry into force of the Ministerial Decree of November 30th, 2021, concerning the…

READ

THE NEW EUROPEAN PORTAL FOR CLINICAL TRIAL SUBMISSION (CLINICAL TRIAL INFORMATION SYSTEM – CTIS)

As of 31st January, 2022, the Clinical Trials Information System (CTIS) has gone live and thus the Clinical Trials Regulation…

READ

EMA PRIME SCHEME: 5 YEAR REVIEW (2015-2021)

On 3rd March 2022 the European Medicines Agency (EMA) released the 5-years report for its PRIME (PRIority MEdicines) scheme, that…

READ

NEW AIFA P&R E-DOSSIER PLATFORM – STATE OF THE ART

Following the provisions of the Ministerial Decree of 2 August 2019 “Criteria and methods by which the Italian Medicines Agency…

READ

MEDICAL DEVICE CLASSIFICATION – FOCUS ON MEDICAL DEVICE SOFTWARE (MDSW)

The Regulation 2017/745 (MDR) introduced several news for software classified as Medical Devices (Medical Device Software, MDSW).Classification Rule 11 and…

READ

ADVERTISING OF MEDICAL DEVICES FOR GENERAL PUBLIC

The Competent Authority for the evaluation of the advertising concerning medical devices in Italy is the Ministry of Health (MoH)….

READ

CLINICAL TRIALS – TRANSITIONAL OPERATING PROCEDURE FOR CLINICAL TRIALS IN ITALY ACCORDING TO REGULATION (EU) NO. 536/2014

With the activation of the CTIS on January 31st 2022, Clinical Trials Regulation (EU) no. 536/2014 has officially entered into…

READ

SCIENTIFIC ADVICE ON MEDICINE REPURPOSING

The European Medicines Agency (EMA) and National Competent Authorities (NCA) are working on a pilot project to offer scientific advice…

READ

THE EPI PROJECT

In March 2017, the European Commission (EC) published its report on current shortcomings in the summary of product characteristics (SmPC)…

READ